| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |